BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16417073)

  • 1. Management of histologic abnormalities of the cervix.
    Spitzer M; Apgar BS; Brotzman GL
    Am Fam Physician; 2006 Jan; 73(1):105-12. PubMed ID: 16417073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
    Kaufman RH; Adam E; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
    Boardman LA; Kennedy CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of cervical cytologic abnormalities.
    Apgar BS; Brotzman G
    Am Fam Physician; 2004 Nov; 70(10):1905-16. PubMed ID: 15571057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology.
    Apgar BS; Kittendorf AL; Bettcher CM; Wong J; Kaufman AJ
    Am Fam Physician; 2009 Jul; 80(2):147-55. PubMed ID: 19621855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of abnormal cervical cytology screening in adolescent and young women in a canadian colposcopy centre: a descriptive analysis.
    Bouchard-Fortier G; Paszat L; Murphy KJ
    J Obstet Gynaecol Can; 2013 Feb; 35(2):149-55. PubMed ID: 23470065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should unsatisfactory colposcopy necessitate treatment of cervical intraepithelial neoplasia 1?
    Day T; Weitzen S; Cooper AS; Boardman LA
    J Low Genit Tract Dis; 2008 Jan; 12(1):11-5. PubMed ID: 18162806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
    Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
    Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy.
    Massad LS; Perkins RB; Naresh A; Nelson EL; Spiryda L; Gecsi KS; Mulhem E; Kostas-Polston E; Zou T; Giles TL; Wentzensen N
    J Low Genit Tract Dis; 2023 Jan; 27(1):97-101. PubMed ID: 36222824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of High-Grade Histopathology Diagnosed by Cervical Conization in Endocervical Curettage Cervical Intraepithelial Neoplasia 1: A Case-Control Study.
    Cong Q; Xiao J; Tao X; Sui L
    J Low Genit Tract Dis; 2020 Jul; 24(3):247-251. PubMed ID: 32324695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of Cervical Precancers by Endocervical Curettage at Colposcopy of Women With Abnormal Cervical Cytology.
    Liu AH; Walker J; Gage JC; Gold MA; Zuna R; Dunn ST; Schiffman M; Wentzensen N
    Obstet Gynecol; 2017 Dec; 130(6):1218-1225. PubMed ID: 29112672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
    Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
    Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
    Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopy.
    van der Marel J; van Baars R; Rodriguez A; Quint WG; van de Sandt MM; Berkhof J; Schiffman M; Torné A; Ordi J; Jenkins D; Verheijen RH; Helmerhorst TJ; Ter Harmsel B; Wentzensen N; Del Pino M
    Gynecol Oncol; 2014 Nov; 135(2):201-7. PubMed ID: 25204846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy.
    Cox JT; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2003 Jun; 188(6):1406-12. PubMed ID: 12824970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of CIN1].
    Rouzier R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S114-20. PubMed ID: 18191500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia.
    Baasland I; Hagen B; Vogt C; Valla M; Romundstad PR
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1258-1263. PubMed ID: 27564523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pregnancy related cervical cytological changes and clinical management].
    Ma L; Bian ML; Liu J; Wang XH; Pang CH; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):84-7. PubMed ID: 21426763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.